Le Lézard
Classified in: Health, Science and technology
Subject: PER

AbleTo Welcomes Distinguished Healthcare Leader Dr. David Shulkin to Board of Directors


NEW YORK, Jan. 17, 2019 /PRNewswire/ -- AbleTo, Inc., a leading provider of virtual behavioral health care proven to improve clinical outcomes and lower healthcare costs, announced today that David J. Shulkin, M.D. joined the company's board of directors. Dr. Shulkin most recently served as the U.S. Secretary of Veterans Affairs.

AbleTo CEO Trip Hofer and recently appointed board member, David J. Shulkin, M.D., at the 2018 AbleTo Behavioral Health Innovation Summit on October 25, 2018 in New York

A board-certified internist, he received his medical degree from the Medical College of Pennsylvania and completed his internship at Yale University School of Medicine. Prior to leading the VA, Dr. Shulkin held numerous chief executive roles at Morristown Medical Center and the Atlantic Health System Accountable Care Organization in New Jersey. He also formerly served as president and CEO of Beth Israel Medical Center in New York.

Dr. Shulkin recently was the featured key note speaker at the 2018 AbleTo Behavioral Health Innovation Summit, where he discussed his work with payers and providers and his efforts to integrate primary care and behavioral health care.

"Dr. Shulkin's experience working in private and public health care provides strategic insight at a time when AbleTo continues to experience significant growth from our health plan partners," said AbleTo CEO Trip Hofer. "He is a medical doctor with a passion for behavioral health and understands that those two areas have to be addressed at the same time. Having Dr. Shulkin on our board reinforces our commitment to delivering treatment that addresses behavioral health with a holistic approach, especially for those with unmet needs."

Dr. Shulkin also has held numerous physician leadership roles, including chief medical officer of the University of Pennsylvania Health System, Temple University Hospital and the Medical College of Pennsylvania Hospital. He has held academic positions, including chairman of medicine and vice dean at Drexel University School of Medicine, and founded and served as chairman and CEO of DoctorQuality, one of the first consumer-oriented sources of information on quality and safety in health care.

"I am honored to join the board of such an innovative organization like AbleTo, one that is committed to breaking down the barriers to behavioral health access at a time when results-oriented programs are needed more than ever," said Dr. Shulkin. "It is absolutely necessary to improve access to high quality behavioral health care for many populations to have a meaningful, lasting impact on overall health. I believe that AbleTo is uniquely positioned to help organizations reach the full potential of integrated behavioral health care."

About AbleTo, Inc.

AbleTo, Inc. is a market leader in providing technology-enabled behavioral health care. AbleTo has been treating patients for over six years, and improves patient outcomes and lowers costs by providing treatment that integrates behavioral and medical health care. AbleTo's structured therapy programs strengthen medical recovery and self-care among members with chronic or complex clinical needs. AbleTo analytics, coupled with our multi-channel engagement platform, identify and engage members with unmet, often undiagnosed, behavioral health needs. A proprietary platform connects individuals and their care teams with AbleTo licensed providers who deliver weekly sessions by phone or video supported by an integrated digital experience. AbleTo programs are clinically proven to improve both behavioral health and medical outcomes while lowering overall spending for higher-cost, higher-risk members. Follow AbleTo on LinkedIn and Twitter.

Media Contact: Mary Mooney, Marketing Director, AbleTo, Inc., 312-593-4280; [email protected]

AbleTo, Inc. (PRNewsfoto/AbleTo, Inc.)

SOURCE AbleTo, Inc.


These press releases may also interest you

at 05:05
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...

at 05:00
Bringing order to chaos is a challenge in the best of circumstances. "We support the Ukrainian people in their fight for freedom in a...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...



News published on and distributed by: